Trial intelligence / Profile preview

Octreotide for nonvariceal upper gastrointestinal bleeding

IRCT2015050322066N1Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Dec 2015
Modality
Peptides
Countries
1
01

Overview

Phase 3 trial of octreotide in upper gastrointestinal bleeding (UGIB), sponsored by Shiraz University of Medical Sciences. Started Dec 2015; status: completed.

02

Drugs

octreotide
03

Conditions

upper gastrointestinal bleeding (UGIB)

Beyond the preview

Go deeper on IRCT2015050322066N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015050322066N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call